Minimizing false-positives in universal newborn hearing screening: A simple solution

被引:53
|
作者
Clemens, CJ
Davis, SA
机构
[1] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA
[2] Moses Cone Hlth Syst, Greensboro, NC USA
[3] Greensboro Area Hlth Educ Ctr, Greensboro, NC USA
关键词
universal newborn hearing screening; screening; false-positive; hearing; audiology; automated auditory brainstem response;
D O I
10.1542/peds.107.3.e29
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background and Objectives. The false-positive rates of previously reported universal newborn hearing screening (UNHS) programs range between 2.5% and 8%. Critics of UNHS programs have claimed that this rate is too high and might lead to a number of the negative effects produced by false-positive screening tests, namely emotional trauma, disease labeling, iatrogenesis from unnecessary testing, and increased expense in terms of time and money. We previously reported, based on some preliminary data, that as many as 80% of newborns who failed the initial hearing screen subsequently passed when they were retested the following day, before being discharged from the hospital. We now present the results of this intervention for our entire UNHS program during a 7-month period. Methods. We analyzed data from 3142 non-neonatal intensive care unit infants screened with an automated auditory brainstem response at the Women's Hospital of Greensboro from November 1, 1999 to May 31, 2000. A protocol was developed wherein all infants who failed the initial UNHS were rescreened with another automated auditory brainstem response before hospital discharge. Data collected included pass/fail rates during the inpatient stay as well as follow-up data and risk factors for congenital hearing loss. Results. Confirmed hearing loss occurred in 8 nonneonatal intensive care unit infants, a rate of 2.5/1000. Eighty percent of newborns who failed the initial hearing screen passed on rescreening before hospital discharge. This produced a false-positive rate of 0.8% and a corresponding positive predictive value of 24%. If inhospital rescreening had not occurred, our false-positive rate and positive predictive value would have been 3.9% and 6.1%, respectively. Conclusions. Our simple intervention of rescreening all infants who failed their initial UNHS before hospital discharge reduced the false-positive rate of UNHS to 0.8%. We suggest that this simple, inexpensive intervention should be instituted for all similar UNHS programs.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Universal Newborn Screening for Hearing Loss
    Jerger, James
    JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY, 2009, 20 (01) : 4 - 4
  • [22] Towards a universal newborn hearing screening
    Psarommatis, IM
    Tsakanikos, MD
    Diamantopoulou, PM
    Douniadakis, DE
    Apostolopoulos, NK
    SCANDINAVIAN AUDIOLOGY, 2001, 30 : 25 - 27
  • [23] Universal newborn hearing screening -: In reply
    Kemper, AR
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2001, 155 (03): : 422 - 422
  • [24] Advocating for Universal Newborn Hearing Screening
    Hollenbeck, Lani
    CREATIVE NURSING, 2008, 14 (02) : 75 - 81
  • [25] Universal newborn hearing screening in 2010
    Choo, Daniel
    Meinzen-Derr, Jareen
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2010, 18 (05): : 399 - 404
  • [26] Universal newborn hearing screening and postnatal hearing loss
    Weichbold, V
    Nekahm-Heis, D
    Welzl-Mueller, K
    PEDIATRICS, 2006, 117 (04) : E631 - E636
  • [27] Comparison of Hearing Screening Protocols for Universal Newborn Hearing Screening In Turkey
    Erturk, Benan Berrin
    Genc, Gulsum Aydan
    Ozkan, Soner
    JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY, 2010, 6 (02): : 223 - 230
  • [28] MINIMIZING FALSE POSITIVE DIAGNOSES IN NEWBORN SCREENING FOR GALACTOSEMIA
    FRAZIER, DM
    CLEMONS, EH
    KIRKMAN, HN
    BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1992, 48 (03): : 199 - 211
  • [29] Cumulative false-positives (FP) in the prostate, lung, colorectal, ovarian (PLCO) cancer screening trial
    Miller, J. H.
    Kramer, B. S.
    Kreimer, A. R.
    Prorok, P. C.
    Xu, J.
    Baker, S. G.
    Fagerstrom, R.
    Berg, C. D.
    Gohagan, J. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] USE OF A TEST DIET IN SCREENING FOR NEUROBLASTOMA REDUCES FALSE-POSITIVES ATTRIBUTABLE TO FOOD-INTAKE
    SAITO, T
    NIKKAWA, T
    USUGANE, T
    OKAMOTO, T
    KOMIYA, H
    ACTA PAEDIATRICA SCANDINAVICA, 1990, 79 (10): : 943 - 949